18.01.2013 13:05 Uhr, Quelle: Wallstreet online

ThromboGenics Receives Positive CHMP Opinion for JETREA®

LEUVEN, Belgium, January 18, 2013 /PRNewswire/ Positive opinion clears the way for the potential EMA approval of JETREA(R)as the first pharmacological option for the treatment of vitreomacular traction (VMT), including when associated with …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz